It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or consider using other browsers such as Chrome, Firefox or Safari.

Your OmniSource® Journey, Step by Step

At the beginning of your journey, you may feel like there are a lot of new and unfamiliar experiences ahead of you.

With OmniSource, youʼll have a whole team of professionals who are there to support you and help to remove any obstacles you may encounter.

While every growth journey is unique, weʼve put together an outline of what you and your family can expect along the way.

doctor icon


To make a diagnosis, your doctor may perform a series of tests such as measuring the amount of growth hormone in the patient’s body

icon of a folder

OmniSource Case Manager

If you and your doctor choose Omnitrope®, your doctor will submit a Statement of Medical Necessity (SMN) to OmniSource.
Within two days, you’ll get a call from your dedicated OmniSource Case Manager (OCM) who will be with you every step of the way.

contact icon


To get started, your OCM will contact your insurance company to make sure you’re eligible to receive Omnitrope. This information may be provided back to your doctor’s office in as little as four hours. If additional Benefits Investigation (BI) and Prior Authorization (PA) information is needed, your OCM will work with your doctor’s office to provide this. They will also help submit an appeal if you are denied coverage.

check list icon

Avoid Delays with OmniStart

If the insurance process takes longer than 10 days, your doctor may recommend the Sandoz OmniStart (SOS) Interim Drug Program, which provides Omnitrope free of charge to patients that qualify.*

chart icon

Your Journey, Your Way

Every growth journey is unique. To make sure you’re getting the personalized support you need, your OCM will reach out to you to explain our program, determine which options are best for you and answer any questions that you might have

syringe icon

Injection Training

We also offer injection training to meet your needs. This includes training at home, over the telephone or by video chat.

savings icon

Co-Pay Savings Program

With our Co-Pay Savings Program, you may be eligible to pay as little as $0 out-of-pocket, with a maximum
benefit of up to $5,000 to be used at any time each year.

milestone chart icon

Staying on Treatment

Starting therapy is just the beginning – that’s why we offer adherence support to keep you on track and help you to celebrate every milestone along the way.

Your Omnisource Team

Meet your OmniSource Team 

Our OmniSource Case Managers and Nurse Trainers will be with you each step of the way.


Get savings support with Co-Pay

Savings support for the journey ahead - eligible patients may pay as little as $0 for their Co-Pay.

Get started with


Personalized support, each step of the way. Click here to enroll.

*Sandoz OmniStart Program:
SOS is available for a maximum of twelve (12) months to commercially insured patients with an FDA-approved Omnitrope indication during first-time benefits investigation and expired prior authorizations. SOS is also available for a maximum of two (2) months to government-insured patients with an FDA-approved Omnitrope indication during first-time benefits investigation only. This program is not health insurance. Product dispensed under SOS is not eligible for claim reimbursement and should not be submitted to any third-party private payer. SOS does not require, nor will be made contingent on, purchase requirements of any kind. Sandoz reserves the right to amend, rescind, or discontinue this program at any time without further notice. Additional eligibility criteria may apply. Contact OmniSource for further details.
Omnitrope Co-Pay Savings Program Eligibility:
The Omnitrope Co-Pay Savings Program provides up to $5,000 in annual co-pay support for Omnitrope prescriptions. With the Omnitrope Co-pay Savings Program, eligible patients may pay $0 for their co-pay. Eligible patients who are commercially insured may receive co-pay support in the amount of up to $5,000 annually, and patients who are uninsured may receive co-pay support in the amount of up to $417 monthly, with an annual cap of $5,000. Prescription must be for an approved indication. This program is not health insurance. Patients are not eligible if prescriptions are paid, in whole or in part, by any state or federally funded programs, including but not limited to Medicare (including Part D, even in the coverage gap) or Medicaid, Medigap, VA, DOD, or TRICARE, or private indemnity, or HMO insurance plans that reimburse you for the entire cost of your prescription drugs, or where prohibited by law. Patients can participate for a maximum of 12 months. Eligible patients must have a first use of the program by December 31 of the current year. Omnitrope Co-pay Savings Program may not be combined with any other rebate, coupon, or offer. Omnitrope Co-Pay Savings Program has no cash value. Sandoz reserves the right to rescind, revoke, or amend this offer without further notice.


Omnitrope is a prescription medicine that contains human growth hormone and is used to treat:

  • Children with growth failure due to growth hormone deficiency (GHD), Prader-Willi Syndrome, Small for Gestational Age, Turner Syndrome, and Idiopathic Short Stature
  • Adults with either adult onset or childhood onset GHD


Who should not take Omnitrope®?

Omnitrope should not be used by children or adults that have:

  • a critical illness caused by certain types of heart or stomach surgery, accidental trauma,  or a sudden and severe breathing problem (respiratory failure)
  • Prader-Willi syndrome who are severely overweight or have a history of breathing problems including sleep apnea
  • cancer or other tumors
  • allergies to growth hormone or any of the ingredients in the medicine
  • certain types of eye problems caused by diabetes
  • closed bone growth plates

What should patients tell their healthcare provider before taking Omnitrope?

Patients should tell their healthcare provider about all of their medical conditions, including if they:

  • have had heart or stomach surgery, trauma, or serious breathing problems
  • have or have had cancer or any tumor
  • have diabetes
  • take any prescription and non-prescription medicines, steroids, vitamins, or herbal supplements
  • are pregnant or breastfeeding, or plan to become pregnant or breastfeed

What are the most common side effects of Omnitrope?

  • local reactions at the injection site (such as pain, numbness, redness and swelling)
  • headaches
  • swelling associated with fluid retention
  • pain in joints and muscle pain
  • carpal tunnel syndrome
  • tingling and numbness
  • high blood sugar (hyperglycemia/diabetes) and sugar in your urine (glucosuria)
  • unusual skin sensations
  • low levels of thyroid hormone (hypothyroidism)

Other possible side effects of Omnitrope are:

  • return of tumor or cancerous growths
  • headaches, changes in vision, nausea or vomiting (these may be symptoms of raised pressure in the brain which requires immediate medical attention)
  • hip and knee pain or a limp in children, that can be a sign of slipped capital femoral epiphysis
  • worsening of pre-existing curvature of the spine in children (scoliosis)
  • increased ear infections and ear disorders in children with Turner syndrome; check for cardiovascular disorders (hypertension, stroke)
  • intense pain and tenderness in the abdomen as consequence of an inflammation of the pancreas (pancreatitis)
  • gasping syndrome (decreased rate of breathing) in children from high levels of benzyl alcohol (an inactive ingredient)
  • Increased mortality in patients with Prader Willi and acute illness

Please see full Prescribing Information for Omnitrope

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit or call 1-800-FDA-1088. To report SUSPECTED ADVERSE REACTIONS, contact Sandoz Inc. at 1-800-525-8747 or FDA at 1-800-FDA-1088 or